Cyberkinetics is an American company with roots tied to the

University of Utah The University of Utah (U of U, UofU, or simply The U) is a public research university in Salt Lake City, Utah. It is the flagship institution of the Utah System of Higher Education. The university was established in 1850 as the University of De ...

. It was co-founded by John Donoghue, Mijail Serruya, Gerhard Friehs of Brown University, and Nicho Hatsopoulos of the

University of Chicago The University of Chicago (UChicago, Chicago, U of C, or UChi) is a private university, private research university in Chicago, Illinois. Its main campus is located in Chicago's Hyde Park, Chicago, Hyde Park neighborhood. The University of Chic ...

. The Braingate technology and related Cyberkinetic’s assets were acquired by BrainGate in 2008. BrainGate, Inc. is a privately held company designing and testing devices for transformative neurotechnologies which can help computers decode the neural signals to operate external devices.Braingate gets a new lease on life
The Boston Globe, August, 2009

Funding

Scientists behind the project used $9.3 million in first round funding led by

Oxford Bioscience Partners Oxford () is a city in England. It is the county town and only city of Oxfordshire. In 2020, its population was estimated at 151,584. It is north-west of London, south-east of Birmingham and north-east of Bristol. The city is home to the ...

. A 2002 merger with Bionic Technologies, co-founded by Brian Hatt and Richard A. Normann (the inventor of the

Utah array Microelectrode arrays (MEAs) (also referred to as multielectrode arrays) are devices that contain multiple (tens to thousands) microelectrodes through which neural signals are obtained or delivered, essentially serving as neural interfaces that co ...

) added to a tech team armed with intellectual property rights gained from Brown,

MIT The Massachusetts Institute of Technology (MIT) is a private land-grant research university in Cambridge, Massachusetts. Established in 1861, MIT has played a key role in the development of modern technology and science, and is one of the m ...

, and others. They say they're three to five years away from putting a product on the market. According to their latest SEC filing, the Founders of the company resigned from the Board of Directors at the end of October 2008.

Merger and renaming

In late 2004, Cyberkinetics initiated a reverse merger with a Texas company in order to gain access to the public market. The resulting company was renamed
Cyberkinetics Neurotechnology Systems, Inc.
' and its shares are listed under the symbol CYKN.OB. In 2009, the

BrainGate BrainGate is a brain implant system built and previously owned by Cyberkinetics, currently under development and in clinical trials, designed to help those who have lost control of their limbs, or other bodily functions, such as patients with am ...

business and related Cyberkinetic assets were sold to privately held Braingate, Inc. In the same year, Cyberkinetics was acquired b
Blackrock Microsystems, LLC

Clinical trials

Since July 8, 2009, clinical trials are being conducted for the Brain Gate 2 Neural Interface System. Since July 16, 2009, the pilot clinical trial of the BrainGate2 Neural Interface System is registered at ClinicalTrials.gov.

References

{{reflist

External links

Blackrock Microsystems Official WebsiteCyberkinetics Neurotechnology Official WebsiteDonoghue LabHatsopoulos Lab BrainGate Official Website
Brain–computer interfacing

Funding

Merger and renaming

Clinical trials

See also

References

External links